Micronized DHACM + Saline Injection

Phase 3Completed

0 views this week 0 watching💤 Quiet

Interest: 34/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Tendonitis;Achilles

Conditions

Tendonitis;Achilles

Trial Timeline

Jan 9, 2018 → Mar 30, 2021

NCT ID

NCT03414255

About Micronized DHACM + Saline Injection

Micronized DHACM + Saline Injection is a phase 3 stage product being developed by MiMedx Group for Tendonitis;Achilles. The current trial status is completed. This product is registered under clinical trial identifier NCT03414255. Target conditions include Tendonitis;Achilles.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT03414255	Phase 3	Completed	Jan 9, 2018	Mar 30, 2021	Tendonitis;Achilles